This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wilburn, R. L. Articles by Bennet, C. M. Search for Related Content PubMed PubMed Citation Articles by Wilburn, R. L. Articles by Bennet, C. M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB FUROSEMIDE HYDRALAZINE HYDROCHLORIDE MINOXIDIL PROPRANOLOL HYDROCHLORIDE Medline Plus Health Information High Blood Pressure

Circulation, Vol 52, 706-713, Copyright © 1975 by American Heart Association

ARTICLES

Long-term treatment of severe hypertension with minoxidil, propranolol and furosemide

RL Wilburn, A Blaufuss and CM Bennet

Thirteen patients with severe hypertension were treated with combined minoxidil, propranolol, and furosemide (mean daily doses 33 mg, 475 mg, and 578 mg, respectively) for nine to twenty-five months (mean 13.8). Average mean blood pressure while on aggressive therapy with conventional medication was 144 +/- 14 mm Hg; on minoxidil and propranolol it was 108 "/- 10 mm Hg (P less thator to optimum blood pressure control and required large doses of furosemide to control. Propranolol blunted the reflex tachycardia associated with arteriolar dilator therapy but all patients continued with a clinically hyperdynamic circulation. Seven of seven had elevated ejection fractions on echocardiogram, and two of three had elevated cardiac indices. Three of three who had heart catheterization had pulmonary hypertension which was aggravated by exercise. An additional three patients on hydralazine, propranolol, and furosemide also had pulmonary hypertension suggesting this is not unique to minoxidil. Two of thirteen developed pericardial effusions. Renal function improved in three and worsened in three.

This article has been cited by other articles:

				S. Spitalewitz, J. G. Porush, and I. W. Reiser Minoxidil, Nadolol, and a Diuretic: Once-a-Day Therapy for Resistant Hypertension Arch Intern Med, May 1, 1986; 146(5): 882 - 886. [Abstract] [PDF]

				S. L. LINAS and A. S. NIES Minoxidil Ann Intern Med, January 1, 1981; 94(1): 61 - 65. [Abstract] [PDF]

				M. C. Houston, J. A. McChesney, and K. Chatterjee Pericardial Effusion Associated With Minoxidil Therapy Arch Intern Med, January 1, 1981; 141(1): 69 - 71. [Abstract] [PDF]

				M. E. Kosman Evaluation of a New Antihypertensive Agent: Minoxidil JAMA, July 4, 1980; 244(1): 73 - 75. [Abstract] [PDF]

				T. Rosenthal, J. Swartz, A. Teicher, and H. Boichis Minoxidil in the Treatment of Refractory Hypertension Angiology, March 1, 1980; 31(3): 176 - 184. [Abstract] [PDF]

				T. Rosenthal, J. Swartz, A. Teicher, and H. Boichis Minoxidil in the Treatment of Refractory Hypertension Angiology, February 1, 1980; 31(2): 109 - 119. [Abstract] [PDF]

				D. Hall, F. Charocopos, K.-L. Froer, and W. Rudolph ECG Changes During Long-term Minoxidil Therapy for Severe Hypertension Arch Intern Med, July 1, 1979; 139(7): 790 - 794. [Abstract] [PDF]

				H. C. Mitchell and W. A. Pettinger Long-Term Treatment of Refractory Hypertensive Patients With Minoxidil JAMA, May 19, 1978; 239(20): 2131 - 2138. [Abstract] [PDF]